Home › Companies › Outset Medical, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Outset Medical, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2026: 4 items on Outset Medical, Inc.’s Form 8-K, filed June 5, 2026: 2 approved · 2 passed (calculated).
Significant dissent: 1 director (24.6% against).
Notable dissent: 1 say-on-pay vote (70.2% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: BML Capital (13F, 13.6%, as of September 30, 2026)
Explore Outset Medical, Inc. in the interactive database Compare manager voting policies
These tallies are Outset Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Brent D. Lang | 8,109,357 | -- | -- | 2,642,698 | 3,138,809 | 75% | Passed (calculated) | — |
| Elect Director: Karen Prange | 10,317,822 | -- | -- | 434,233 | 3,138,809 | 96% | Passed (calculated) | — |
| 2. Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2025 compensation of the Company's named executive officers as disclosed in its 2026 proxy statement on a non-binding advisory basis | 7,548,774 | 3,196,870 | 6,411 | -- | 3,138,809 | 70% | Approved | — |
| 3. Ratification of Appointment of Independent Registered Public Accounting Firm | 13,554,287 | 20,047 | 316,530 | -- | -- | 99.9% | Approved | — |
Source: Outset Medical, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
114 asset managers disclosed a vote on at least one Outset Medical, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Brent D. Lang
Outset Medical, Inc.’s own tally for this item (“Elect Director: Brent D. Lang”): 8,109,357 for, 2,642,698 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 4,248,176 for, 178,032 withheld, 4 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,783,364 | 0 | 0 | 0 | For |
| Vanguard | 850,596 | 0 | 4 | 0 | For |
| BlackRock | 374,780 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 82,875 | Withhold |
| Charles Schwab | 41,162 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 0 | 36,503 | Withhold |
| JPMorgan | 36,490 | 0 | 0 | 0 | For |
| TIAA | 34,957 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 30,333 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 26,943 | Withhold |
| Lincoln Financial | 21,724 | 0 | 0 | 0 | For |
| Equitable | 12,958 | 0 | 0 | 6,400 | Mixed |
| T. Rowe Price | 15,464 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 9,397 | Withhold |
| Goldman Sachs | 8,756 | 0 | 0 | 0 | For |
| Global X | 8,298 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,520 | 0 | 0 | 0 | For |
| State Street | 5,878 | 0 | 0 | 0 | For |
| Pacific Life | 5,731 | 0 | 0 | 0 | For |
| Voya | 5,121 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 3,783 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 3,525 | Withhold |
| SEI | 2,600 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 2,481 | Withhold |
| ProShares | 0 | 0 | 0 | 2,262 | Withhold |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Karen Prange
Outset Medical, Inc.’s own tally for this item (“Elect Director: Karen Prange”): 10,317,822 for, 434,233 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 4,410,747 for, 15,464 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,783,364 | 0 | 0 | 0 | For |
| Vanguard | 850,599 | 0 | 1 | 0 | For |
| BlackRock | 374,780 | 0 | 0 | 0 | For |
| Dimensional | 82,875 | 0 | 0 | 0 | For |
| Charles Schwab | 41,162 | 0 | 0 | 0 | For |
| AQR | 36,503 | 0 | 0 | 0 | For |
| JPMorgan | 36,490 | 0 | 0 | 0 | For |
| TIAA | 34,957 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 30,333 | 0 | 0 | 0 | For |
| American Century | 26,943 | 0 | 0 | 0 | For |
| Lincoln Financial | 21,724 | 0 | 0 | 0 | For |
| Equitable | 19,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 15,464 | Withhold |
| AIG/SunAmerica | 9,397 | 0 | 0 | 0 | For |
| Goldman Sachs | 8,756 | 0 | 0 | 0 | For |
| Global X | 8,298 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,520 | 0 | 0 | 0 | For |
| State Street | 5,878 | 0 | 0 | 0 | For |
| Pacific Life | 5,731 | 0 | 0 | 0 | For |
| Voya | 5,121 | 0 | 0 | 0 | For |
| John Hancock | 3,783 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 3,525 | 0 | 0 | 0 | For |
| SEI | 2,600 | 0 | 0 | 0 | For |
| DWS | 2,481 | 0 | 0 | 0 | For |
| ProShares | 2,262 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
70% Approved · of votes cast
Prior year: 97.5% for (June 2, 2025 meeting) ▼ 27.3 pts
Description as filed by funds: TO APPROVE, ON A NON-BINDING BASIS, THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Outset Medical, Inc.’s own tally for this item (“2. Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2025 compensation of the Company's named executive officers as disclosed in its 2026 proxy statement on a non-binding advisory basis”): 7,548,774 for, 3,196,870 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two: Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2025 compensation of the Company's named executive officers as disclosed in its 2026 proxy statement on a non-binding advisory basis was approved by the following vote: Since the Board is divided into th…”
Support: 70% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,783,364 | 0 | 0 | 0 | For |
| Vanguard | 850,594 | 6 | 0 | 0 | For |
| BlackRock | 374,780 | 0 | 0 | 0 | For |
| Dimensional | 0 | 82,875 | 0 | 0 | Against |
| Charles Schwab | 41,162 | 0 | 0 | 0 | For |
| AQR | 0 | 36,503 | 0 | 0 | Against |
| JPMorgan | 36,490 | 0 | 0 | 0 | For |
| TIAA | 0 | 34,957 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 30,333 | 0 | 0 | 0 | For |
| American Century | 0 | 26,943 | 0 | 0 | Against |
| Lincoln Financial | 21,724 | 0 | 0 | 0 | For |
| Equitable | 12,958 | 6,400 | 0 | 0 | Mixed |
| T. Rowe Price | 0 | 15,464 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 9,397 | 0 | 0 | Against |
| Goldman Sachs | 8,756 | 0 | 0 | 0 | For |
| Global X | 8,298 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,520 | 0 | 0 | 0 | For |
| State Street | 5,878 | 0 | 0 | 0 | For |
| Pacific Life | 5,731 | 0 | 0 | 0 | For |
| Voya | 0 | 5,121 | 0 | 0 | Against |
| John Hancock | 0 | 3,783 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 3,525 | 0 | 0 | Against |
| SEI | 2,600 | 0 | 0 | 0 | For |
| DWS | 0 | 2,481 | 0 | 0 | Against |
| ProShares | 0 | 2,262 | 0 | 0 | Against |
Fund voting reports, all 34 managers: 4,192,632 for, 233,580 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,531,849 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 526,300 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 0 | 523,333 | 0 | 0 | Against |
| Invesco | 0 | 512,754 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 421,373 | 0 | 0 | 0 | For |
| AQR | 0 | 321,748 | 0 | 0 | Against |
| State Street | 305,808 | 2,471 | 0 | 0 | For |
| BlackRock | 266,124 | 22 | 0 | 0 | For |
| Vanguard | 116,241 | 3,789 | 0 | 0 | For |
| Catalio Capital Management, LP | 118,279 | 0 | 0 | 0 | For |
| Northern Trust | 89,421 | 5,036 | 0 | 0 | Mixed |
| T. Rowe Price | 0 | 81,909 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 75,897 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 70,140 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 66,666 | 0 | 0 | Against |
| Nuveen | 0 | 65,585 | 0 | 0 | Against |
| National Bank Financial Inc. | 0 | 0 | 0 | 0 | Not Voted |
| MELLON INVESTMENTS Corp | 0 | 44,913 | 0 | 0 | Against |
| Charles Schwab | 41,162 | 0 | 0 | 0 | For |
| American Century | 0 | 26,943 | 0 | 0 | Against |
| Woodline Partners LP | 24,081 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 23,718 | 0 | 0 | Against |
| Goldman Sachs | 18,390 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 17,374 | 0 | 0 | Against |
| JPMorgan | 14,077 | 0 | 0 | 0 | For |
Institutional-manager reports, all 95 managers: 4,671,694 for, 1,762,134 against, 46,164 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 99.9% for (June 2, 2025 meeting) ▼ 0.1 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2026.
Outset Medical, Inc.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 13,554,287 for, 20,047 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 4,426,211 for, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,783,364 | 0 | 0 | 0 | For |
| Vanguard | 850,599 | 0 | 1 | 0 | For |
| BlackRock | 374,780 | 0 | 0 | 0 | For |
| Dimensional | 82,875 | 0 | 0 | 0 | For |
| Charles Schwab | 41,162 | 0 | 0 | 0 | For |
| AQR | 36,503 | 0 | 0 | 0 | For |
| JPMorgan | 36,490 | 0 | 0 | 0 | For |
| TIAA | 34,957 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 30,333 | 0 | 0 | 0 | For |
| American Century | 26,943 | 0 | 0 | 0 | For |
| Lincoln Financial | 21,724 | 0 | 0 | 0 | For |
| Equitable | 19,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 15,464 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,397 | 0 | 0 | 0 | For |
| Goldman Sachs | 8,756 | 0 | 0 | 0 | For |
| Global X | 8,298 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,520 | 0 | 0 | 0 | For |
| State Street | 5,878 | 0 | 0 | 0 | For |
| Pacific Life | 5,731 | 0 | 0 | 0 | For |
| Voya | 5,121 | 0 | 0 | 0 | For |
| John Hancock | 3,783 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 3,525 | 0 | 0 | 0 | For |
| SEI | 2,600 | 0 | 0 | 0 | For |
| DWS | 2,481 | 0 | 0 | 0 | For |
| ProShares | 2,262 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 18,537,241 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 15.01% |
| 2 | Vanguard | 4.59% |
| 3 | BlackRock | 2.02% |
| 4 | Dimensional | 0.45% |
| 5 | Charles Schwab | 0.22% |
| 6 | AQR | 0.20% |
| 7 | JPMorgan | 0.20% |
| 8 | TIAA | 0.19% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.16% |
| 10 | American Century | 0.15% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 13.66% |
| 2 | Ensign Peak Advisors, Inc | 2.84% |
| 3 | PFM Health Sciences, LP | 2.82% |
| 4 | Invesco | 2.77% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.27% |
| 6 | AQR | 1.74% |
| 7 | State Street | 1.66% |
| 8 | BlackRock | 1.44% |
| 9 | Vanguard | 0.65% |
| 10 | Catalio Capital Management, LP | 0.64% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 2,741,673 | 14.79% | Form 13F, quarter ended March 31, 2026 |
| BML Investment Partners, L.P. | 2,519,701 | 13.59% | Schedule 13G, filed May 18, 2026 |
| BlackRock | 1,263,219 | 6.81% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 977,969 | 5.28% | Form 13F, quarter ended March 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 666,596 | 3.60% | Schedule 13G, filed August 12, 2026 |
| PFM Health Sciences, LP | 530,796 | 2.86% | Schedule 13G, filed February 17, 2026 |
| Geode Capital | 421,373 | 2.27% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 353,200 | 1.91% | Form 13F, quarter ended March 31, 2026 |
| State Street | 334,994 | 1.81% | Form 13F, quarter ended March 31, 2026 |
| Woodline Partners LP | 292,437 | 1.58% | Schedule 13G, filed May 15, 2026 |
Percentages above are of 18,537,241 shares outstanding, as reported by Outset Medical, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Outset Medical, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 114 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 516 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING BASIS, THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — Outset Medical, Inc.'s filing reports the proposal as approved, with 70% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Outset Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Outset Medical, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Outset Medical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Outset Medical (OM) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/outset-medical-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.